Administration of second dose of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (procedure)
SCTID: 1157197009, Primitive, Active
1157197009|Administration of second dose of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (procedure)|
- en Administration of second dose of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen
- en Administration of second dose of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (procedure)
- en Second dose of inactivated whole severe acute respiratory syndrome coronavirus 2 antigen vaccination
- en Administration of second dose of inactivated whole sars-cov-2 antigen vaccine
- en Second dose of inactivated whole 2019-ncov antigen immunisation
- en Second dose of inactivated whole 2019-ncov antigen immunization
- en Second dose of inactivated whole 2019-ncov antigen vaccination
- en Second dose of inactivated whole 2019 novel coronavirus antigen immunisation
- en Second dose of inactivated whole 2019 novel coronavirus antigen immunization
- en Second dose of inactivated whole 2019 novel coronavirus antigen vaccination
- en Second dose of inactivated whole covid-19 antigen immunisation
- en Second dose of inactivated whole covid-19 antigen immunization
- en Second dose of inactivated whole covid-19 antigen vaccination
- en Second dose of inactivated whole sars-cov-2 antigen immunization
- en Second dose of inactivated whole sars-cov-2 antigen vaccination